Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEFIBROTIDE Cause Condition aggravated? 78 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Condition aggravated have been filed in association with DEFIBROTIDE (DEFITELIO). This represents 2.1% of all adverse event reports for DEFIBROTIDE.

78
Reports of Condition aggravated with DEFIBROTIDE
2.1%
of all DEFIBROTIDE reports
59
Deaths
16
Hospitalizations

How Dangerous Is Condition aggravated From DEFIBROTIDE?

Of the 78 reports, 59 (75.6%) resulted in death, 16 (20.5%) required hospitalization, and 17 (21.8%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEFIBROTIDE. However, 78 reports have been filed with the FAERS database.

What Other Side Effects Does DEFIBROTIDE Cause?

Off label use (1,323) Venoocclusive disease (576) Death (463) Multiple organ dysfunction syndrome (372) Venoocclusive liver disease (355) Intentional product use issue (201) Hypotension (169) Haemorrhage (156) Sepsis (143) Acute graft versus host disease (140)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which DEFIBROTIDE Alternatives Have Lower Condition aggravated Risk?

DEFIBROTIDE vs DEFLAZACORT DEFIBROTIDE vs DEGARELIX DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE DEFIBROTIDE vs DELAMANID DEFIBROTIDE vs DELANDISTROGENE MOXEPARVOVEC-ROKL

Related Pages

DEFIBROTIDE Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated DEFIBROTIDE Demographics